New Spatial Proteomics Workflow Maps Thymus Recovery After Chemotherapy

The thymus is the primary organ responsible for generating functional T cells, yet its architecture is exquisitely sensitive to cytotoxic insults such as chemotherapy. After treatment, the thymus undergoes involution — shrinkage and disruption of its cortex and medulla — followed by a slow regenerative process. Understanding which proteins drive this recovery, and where they are expressed within the tissue, is critical for developing strategies to accelerate immune reconstitution in patients, particularly children receiving intensive cancer therapies.

To address this, the researchers developed a hybrid spatial proteomics workflow. They applied matrix-assisted laser desorption/ionization mass spectrometry imaging (MALDI-MSI) directly to thin sections of murine thymus tissue, generating pixel-by-pixel maps of molecular signals across the organ. MALDI-MSI offers the advantage of being antibody-free and highly multiplexed, but its core limitation — an inability to unambiguously identify the proteins behind each signal — has historically constrained its utility. The team paired MALDI-MSI with conventional liquid chromatography-tandem mass spectrometry (LC-MS/MS) to obtain definitive protein identifications.

The critical innovation is pepBridge, a custom scoring algorithm that aligns MALDI-MSI molecular signals with LC-MS/MS peptide identifications. By bridging these two data streams, pepBridge assigns confident protein identities to MALDI imaging signals, effectively overcoming the identification bottleneck that has long limited spatial mass spectrometry approaches. The workflow was applied to murine thymus tissue from control animals and animals subjected to chemotherapy-induced involution and regeneration.

The pipeline revealed spatially resolved changes in proteins involved in cytoskeletal remodeling, cell migration, and endogenous thymic regeneration — biological processes central to thymocyte trafficking and stromal reorganization during recovery. Most notably, Nucleoprotein TPR, a nuclear pore complex component involved in chromatin organization and mRNA export, and Tubulin-associated chaperone A (TBCA), a co-chaperone critical for tubulin folding and cytoskeletal integrity, both showed distinct spatial shifts corresponding to chemotherapy-driven architectural remodeling. These shifts offer candidate biomarkers and mechanistic targets for intervention.

From a translational standpoint, the authors highlight relevance for pediatric oncology. Children undergoing cytoreductive therapies experience prolonged immunodeficiency partly because thymic recovery is slow and incompletely understood at the molecular level. By identifying specific proteins and pathways whose spatial organization changes during involution and regeneration, this work provides a foundation for therapeutic targeting. The authors position their framework as generalizable to other lymphoid and non-lymphoid tissues, potentially broadening the scope of spatial proteomics across biomedical research.